Exclusive

Publication

Byline

Why Metropolis Healthcare is banking on acquisitions to fuel growth

New Delhi, Sept. 23 -- After aggressive organic expansion between FY21 and FY25, when it added nearly 90 labs and more than doubled its patient service centres from 251 to 530, Metropolis Healthcare L... Read More


Sun Pharma has shuffled its top deck. The bet is on.

Mumbai, Sept. 20 -- Sun Pharmaceutical Industries Ltd, India's largest drugmaker, is steering itself onto a new course with sweeping leadership changes. Starting this month, Kirti Ganorkar, who heade... Read More


Will legal troubles in the US weigh on India's obesity drug boom?

New Delhi, Sept. 17 -- Indian drugmakers queuing up to launch copies of blockbuster weight-loss drugs Ozempic and Wegovy next year might have a perception crisis on their hands. More than 1,800 court ... Read More


Apollo Hospitals to up stake in retail health subsidiary for Rs.1,254 crore

New Delhi, Sept. 12 -- Apollo Hospitals Enterprise Ltd on Friday announced that it will acquire a 31% stake in its subsidiary Apollo Health and Lifestyle Ltd from International Finance Corporation for... Read More


Superbugs are rising. India's scientists are fighting back

New Delhi, Sept. 8 -- Mumbai: Over a decade ago, global pharma major AstraZeneca started pulling out of anti-infectives research. In 2014, it shuttered an Indian research site in Bengaluru, axing earl... Read More


Will he, won't he-Trump's tariff haze has pharma investors on the edge

New Delhi, Sept. 5 -- The uncertainty over tariffs being imposed on pharmaceuticals by the US is making investors cautious about the sector. The market makes for a large chunk of revenue of India's to... Read More


Zydus arm reports positive results for liver disease drug, eyes FDA filing in 2026

New Delhi, Aug. 29 -- Zydus Therapeutics, a subsidiary of Zydus Lifesciences, said on Friday that its investigational drug Saroglitazar showed positive results in a late-stage trial for patients with ... Read More


Aragen Life Sciences eyes IPO as it expands global footprint with biologics, ADCs

Mumbai, Aug. 29 -- Goldman Sachs-backed Aragen Life Sciences Ltd is stepping up expansion across biologics and high-potency therapeutics while preparing for an eventual public listing, its top executi... Read More


Mint Explainer | First Dr Reddy's, now Natco: Why Indian drugmakers are suing Novo Nordisk

New Delhi, Aug. 25 -- Two Indian drugmakers have filed lawsuits against Danish drugmaker Novo Nordisk over its blockbuster weight-loss drug semaglutide, which is set to lose its patent in India in Mar... Read More


Apollo Hospitals' Suneeta Reddy sells 1.3% stake to reduce promoter debt

New Delhi, Aug. 22 -- Apollo Hospitals Enterprises Ltd's managing director Suneeta Reddy offloaded a partial stake in the company on Friday via a block deal to pare the promoter group's outstanding de... Read More